Drug shortage
Belladonna and Opium Suppository · Padagis US LLC
FDA drug shortage · To Be Discontinued · updated Jul 23, 2026
Key facts
| Generic name | Belladonna and Opium Suppository |
|---|---|
| Company | Padagis US LLC |
| Presentation | Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) |
| Dosage form | Suppository |
| Status | To Be Discontinued |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 0574-7045-12 |
| First posted | Jul 23, 2026 |
| Last updated | Jul 23, 2026 |
| Discontinued | Jul 23, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: